Search

Mootha Lab uses human genetics and genomics to understand the molecular basis of Fuchs' endothelial corneal dystrophy and develop novel therapeutic strategies.

Zhang (Chun-Li) Lab research focuses on cellular plasticity in the adult nervous system and modeling human neurodegenerative diseases. We use cell culture and genetically modified mice as model systems. Molecular, cellular, electrophysiological, and behavioral methods are employed.

Skip to main content Contact Us Kosuke Izumi Laboratory UT Southwestern Medical Center 5323 Harry Hines Blvd. K4.210 Dallas, TX 75235-8534 Kosuke Izumi, M.D., Ph.D. | Email RESEARCH OPPORTUNITIES If you are looking for a position as a Post-Doc or Research Assistant at Izumi Lab, please send a stateme…

Skip to main content Meet the PI Xing Chao, Ph.D. Education / Training 1996-2000: Peking University, China, B.S., Biology 2001-2006: Case Western Reserve University, Ph.D., Genetic Epidemiology, Mentor: Robert C. Elston Positions 2014 - present: Associate Professor, UT Southwestern Medical Center, De…

Skip to main content Meet Dr. Azab Current Lab Members Lab Alumni Education 2007-2012 | Harvard Medical School/ Dana-Farber Cancer Institute, Boston, MA Title: Post Doctoral Fellow Specialty: Cancer Cell Biology and Immunology (Prof. Irene Ghobrial Lab) 2003-2007 | The Hebrew University of Jerusalem,…

Publications for Dr. Emina Huang's Lab

Skip to main content Contact Us Matthew Mitsche, Ph.D. Assistant Professor Center for Human Nutrition Molecular Genetics Phone: 214-648-6614 Email Mailing Address UT Southwestern Medical Center 5323 Harry Hines Blvd. K5.140 Dallas, Texas 75390-9014

Skip to main content Post-squalene Cholesterol Biosynthetic Pathways There has been an outstanding debate over the route of cholesterol biosynthesis since it was first discovered in the 1950s. Two alternative pathways have been proposed, the Bloch and Kandutsch-Russell pathways. Using deuterium water…

The ultimate goal of the Nijhawan-De Branander Lab is to discover first in class drugs for the treatment of cancer. 

The central goal of the Dauer Lab is to unravel the molecular and cellular mechanisms of diseases that disrupt the motor system. In exploring these diseases, we also aim to understand a fundamental question relevant to CNS disease generally: what factors determine the selective vulnerability of particular cell types or circuits to insults? Our primary focus is on Parkinson’s disease and inherited forms of dystonia. We focus our efforts on disease genes that cause these disorders, employing a range of molecular, cellular, and whole animal studies to dissect the normal role of disease proteins, and how pathogenic mutations lead to disease.